ProSperACC-1: Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer (clinicaltrials.gov) - Dec 12, 2022 - P1 | N=56 | Not yet recruiting | Sponsor: University Hospital Tuebingen
New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|